HEALIOS K.K. 4593Short Interest
Estimated short interest in HEALIOS K.K. (4593) is 10.20% of shares outstanding as of 2026-11-18. Institutions holding 0.5% or more: Morgan Stanley MUFG Securities Co., Ltd., GOLDMAN SACHS INTERNATIONAL, Barclays Capital Securities Ltd and 2 others.
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It excludes 2 institutions whose last report is more than a year old (2.38% in total). It also excludes 13 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2018-03-14 |
|---|---|
| Latest disclosure | 2026-11-17 (Daiwa Securities Co. Ltd., 0.61%) |
| Reporting institutions | 22 firms (1921 reports) |
| Peak estimated short interest | 20.51% (2025-05-07, 8 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Morgan Stanley MUFG Securities Co., Ltd.
- GOLDMAN SACHS INTERNATIONAL
- Barclays Capital Securities Ltd
- JPM Securities Japan Co Ltd.
- Daiwa Securities Co. Ltd.
- Others
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2026-11-16 | Morgan Stanley MUFG Securities Co., Ltd. | Position 4,876,831 shares | Ratio 3.59% | ▲0.11% | Holding |
| 2026-11-06 | GOLDMAN SACHS INTERNATIONAL | Position 3,896,228 shares | Ratio 2.87% | ▼0.09% | Holding |
| 2023-06-23 | Maven Investment Partners Limited | Position 1,077,400 shares | Ratio 1.69% | ▲0.23% | No report for 1+ year |
| 2026-11-16 | Barclays Capital Securities Ltd | Position 2,284,382 shares | Ratio 1.68% | ▼0.07% | Holding |
| 2026-11-12 | JPM Securities Japan Co Ltd. | Position 1,970,186 shares | Ratio 1.45% | ▲0.09% | Holding |
| 2024-08-16 | Arrowstreet EAFE Alpha Extension Trust Fund | Position 622,700 shares | Ratio 0.69% | ▼0.06% | No report for 1+ year |
| 2026-11-17 | Daiwa Securities Co. Ltd. | Position 829,833 shares | Ratio 0.61% | ▲0.11% | Holding |
| 2021-09-16 | Linden Capital L.P. | Position 245,942 shares | Ratio 0.48% | ▼0.02% | Below 0.5% |
| 2024-08-21 | series ARROWSTREET EAFE ALPHA EXTENSION TRUST FUND A SUB FUND OF ARROWSTREET INVESTMENT TRUST | Position 438,700 shares | Ratio 0.48% | ▼0.11% | Below 0.5% |
| 2021-07-01 | Wellington Management Company LLP on behalf of Hawkes Bay Master Investors (Cayman) LP | Position 248,300 shares | Ratio 0.47% | ▼0.12% | Below 0.5% |
| 2023-07-11 | BNP Paribas Arbitrage SNC | Position 298,400 shares | Ratio 0.46% | ▼0.08% | Below 0.5% |
| 2025-06-25 | UBS AG | Position 474,900 shares | Ratio 0.45% | ▼0.19% | Below 0.5% |
| 2026-08-28 | Barclays Bank PLC | Position 616,262 shares | Ratio 0.45% | ▼0.06% | Below 0.5% |
| 2025-04-18 | XTX Markets Pte Ltd | Position 450,700 shares | Ratio 0.44% | ▼0.06% | Below 0.5% |
| 2026-08-31 | Diversified Select Opportunities, LLC | Position 583,400 shares | Ratio 0.43% | ▼0.19% | Below 0.5% |
| 2025-06-10 | Citigroup Global Markets Limited | Position 410,800 shares | Ratio 0.40% | ▼0.28% | Below 0.5% |
| 2024-08-13 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 286,999 shares | Ratio 0.31% | ▼0.28% | Below 0.5% |
| 2025-11-11 | MERRILL LYNCH INTERNATIONAL | Position 226,888 shares | Ratio 0.19% | ▼0.32% | Below 0.5% |
| 2025-10-21 | Qube Research & Technologies Limited | Position 211,100 shares | Ratio 0.18% | ▼0.43% | Below 0.5% |
| 2026-07-29 | Nomura International plc | Position 167,577 shares | Ratio 0.12% | ▼0.59% | Below 0.5% |
| 2023-01-27 | Janus Henderson Group plc | Position 0 shares | Ratio 0.00% | ▼0.68% | Closed |
| 2024-08-21 | Morgan Stanley & Co. International plc | Position 0 shares | Ratio 0.00% | ▼1.13% | Closed |
Disclosure History 1921 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-11-17 | Daiwa Securities Co. Ltd. | Position 829,833 shares | Ratio 0.61% | ▲0.11% | — |
| 2026-11-16 | Barclays Capital Securities Ltd | Position 2,284,382 shares | Ratio 1.68% | ▼0.07% | — |
| 2026-11-16 | Morgan Stanley MUFG Securities Co., Ltd. | Position 4,876,831 shares | Ratio 3.59% | ▲0.11% | — |
| 2026-11-13 | Barclays Capital Securities Ltd | Position 2,378,682 shares | Ratio 1.75% | ▼0.14% | — |
| 2026-11-12 | JPM Securities Japan Co Ltd. | Position 1,970,186 shares | Ratio 1.45% | ▲0.09% | — |
| 2026-11-11 | Barclays Capital Securities Ltd | Position 2,574,082 shares | Ratio 1.89% | ▼0.04% | — |
| 2026-11-10 | JPM Securities Japan Co Ltd. | Position 1,852,086 shares | Ratio 1.36% | ▼0.04% | — |
| 2026-11-09 | JPM Securities Japan Co Ltd. | Position 1,900,486 shares | Ratio 1.40% | ▼0.24% | — |
| 2026-11-06 | JPM Securities Japan Co Ltd. | Position 2,224,286 shares | Ratio 1.64% | ▼0.19% | — |
| 2026-11-06 | GOLDMAN SACHS INTERNATIONAL | Position 3,896,228 shares | Ratio 2.87% | ▼0.09% | — |
| 2026-11-06 | Barclays Capital Securities Ltd | Position 2,624,782 shares | Ratio 1.93% | ▼0.17% | — |
| 2026-11-05 | Barclays Capital Securities Ltd | Position 2,853,182 shares | Ratio 2.10% | ▲0.06% | — |
| 2026-11-04 | JPM Securities Japan Co Ltd. | Position 2,491,786 shares | Ratio 1.83% | ▼0.12% | — |
| 2026-11-02 | JPM Securities Japan Co Ltd. | Position 2,649,786 shares | Ratio 1.95% | ▼0.13% | — |
| 2026-11-02 | Barclays Capital Securities Ltd | Position 2,774,082 shares | Ratio 2.04% | ▲0.06% | — |
| 2026-10-29 | JPM Securities Japan Co Ltd. | Position 2,832,086 shares | Ratio 2.08% | ▼0.02% | — |
| 2026-10-28 | JPM Securities Japan Co Ltd. | Position 2,854,486 shares | Ratio 2.10% | ▲0.10% | — |
| 2026-10-28 | Barclays Capital Securities Ltd | Position 2,690,382 shares | Ratio 1.98% | ▼0.20% | — |
| 2026-10-26 | JPM Securities Japan Co Ltd. | Position 2,715,186 shares | Ratio 2.00% | ▲0.03% | — |
| 2026-10-21 | JPM Securities Japan Co Ltd. | Position 2,671,386 shares | Ratio 1.97% | ▼0.22% | — |
| 2026-10-20 | Barclays Capital Securities Ltd | Position 2,955,700 shares | Ratio 2.18% | ▲0.10% | — |
| 2026-10-19 | GOLDMAN SACHS INTERNATIONAL | Position 4,014,528 shares | Ratio 2.96% | ▲0.16% | — |
| 2026-10-19 | Barclays Capital Securities Ltd | Position 2,822,100 shares | Ratio 2.08% | ▲0.10% | — |
| 2026-10-16 | Barclays Capital Securities Ltd | Position 2,686,200 shares | Ratio 1.98% | ▲0.10% | — |
| 2026-10-15 | Barclays Capital Securities Ltd | Position 2,554,500 shares | Ratio 1.88% | ▲0.27% | — |
| 2026-10-14 | JPM Securities Japan Co Ltd. | Position 2,981,772 shares | Ratio 2.19% | ▼0.01% | — |
| 2026-10-09 | JPM Securities Japan Co Ltd. | Position 2,987,572 shares | Ratio 2.20% | ▲0.15% | — |
| 2026-10-08 | GOLDMAN SACHS INTERNATIONAL | Position 3,804,328 shares | Ratio 2.80% | ▲0.10% | — |
| 2026-10-06 | JPM Securities Japan Co Ltd. | Position 2,779,672 shares | Ratio 2.05% | ▲0.07% | — |
| 2026-10-06 | Barclays Capital Securities Ltd | Position 2,193,700 shares | Ratio 1.61% | ▼0.13% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
| Renascience Inc.4889 | 6.87% | 3 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| Medrx Co.,Ltd.4586 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| PeptiDream Inc.4587 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Mid400 |
| Oncolys BioPharma Inc.4588 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| RIBOMIC Inc.4591 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| SanBio Company Limited4592 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| BrightPath Biotherapeutics Co.,Ltd.4594 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| MIZUHO MEDY CO.,LTD.4595 | Standard Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Kubota Pharmaceutical Holdings Co.,Ltd.4596 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Solasia Pharma K.K.4597 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Delta-Fly Pharma,Inc.4598 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical |